These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37163090)

  • 1. Network Analysis of Neuropsychiatric Symptoms in Alzheimer's Disease.
    Goodwin GJ; Moeller S; Nguyen A; Cummings JL; John SE
    Res Sq; 2023 Apr; ():. PubMed ID: 37163090
    [No Abstract]   [Full Text] [Related]  

  • 2. Network analysis of neuropsychiatric symptoms in Alzheimer's disease.
    Goodwin GJ; Moeller S; Nguyen A; Cummings JL; John SE
    Alzheimers Res Ther; 2023 Aug; 15(1):135. PubMed ID: 37568209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
    Trzepacz PT; Saykin A; Yu P; Bhamditipati P; Sun J; Dennehy EB; Willis B; Cummings JL;
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):607-22. PubMed ID: 23602309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between dementia staging, neuropsychiatric behavioral symptoms, and divorce or separation in late life: A case control study.
    Monin JK; McAvay G; Zang E; Vander Wyk B; Carrión CI; Allore H
    PLoS One; 2023; 18(8):e0289311. PubMed ID: 37585365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric Symptoms and the Diagnostic Stability of Mild Cognitive Impairment.
    Sugarman MA; Alosco ML; Tripodis Y; Steinberg EG; Stern RA
    J Alzheimers Dis; 2018; 62(4):1841-1855. PubMed ID: 29614641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits.
    Wiels WA; Wittens MMJ; Zeeuws D; Baeken C; Engelborghs S
    Front Psychiatry; 2021; 12():707580. PubMed ID: 34483998
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of the Neuropsychiatric Inventory Questionnaire (NPI-Q) in the assessment of a sample of patients with Alzheimer's disease in Chile.
    Musa G; Henríquez F; Muñoz-Neira C; Delgado C; Lillo P; Slachevsky A
    Dement Neuropsychol; 2017; 11(2):129-136. PubMed ID: 29213504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
    Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
    Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes.
    De Vito AN; Calamia M; Weitzner DS; Bernstein JPK;
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1627-1634. PubMed ID: 30276884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death.
    Qiu J; Goldstein FC; Hanfelt JJ
    Am J Geriatr Psychiatry; 2022 Aug; 30(8):925-934. PubMed ID: 35067420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.
    Sano M; Zhu CW; Neugroschl J; Grossman HT; Schimming C; Aloysi A
    Am J Geriatr Psychiatry; 2022 Nov; 30(11):1198-1208. PubMed ID: 35562259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between clinical dementia rating and clinical outcomes in Alzheimer's disease.
    Lanctôt KL; Boada M; Tariot PN; Dabbous F; Hahn-Pedersen J; Udayachalerm S; Raket LL; Saiontz-Martinez C; Michalak W; Weidner W; Cummings J
    Alzheimers Dement (Amst); 2024; 16(1):e12522. PubMed ID: 38239329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of caregiver demographic variables with neuropsychiatric symptoms in Alzheimer's disease patients for distress on the Neuropsychiatric Inventory (NPI).
    Godinho C; Camozzato A; Kochhann R; Chaves MLF
    Dement Neuropsychol; 2008; 2(3):211-216. PubMed ID: 29213573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
    Ng KP; Pascoal TA; Mathotaarachchi S; Chan YH; Jiang L; Therriault J; Benedet AL; Shin M; Kandiah N; Greenwood CMT; Rosa-Neto P; Gauthier S;
    Transl Neurodegener; 2021 Jan; 10(1):1. PubMed ID: 33390174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study.
    Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer's disease.
    Gumus M; Multani N; Mack ML; Tartaglia MC;
    Geroscience; 2021 Feb; 43(1):213-223. PubMed ID: 33420706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.
    Kaufer DI; Cummings JL; Christine D; Bray T; Castellon S; Masterman D; MacMillan A; Ketchel P; DeKosky ST
    J Am Geriatr Soc; 1998 Feb; 46(2):210-5. PubMed ID: 9475452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.